Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.
Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.
复制标题
DOI:
10.1016/j.ahj.2017.06.016
复制
发表时间:
2017-09
影响因子:
4.8
通讯作者:
HF-ACTION investigators
中科院分区:
文献类型:
--
作者:
Luo N;Teng TK;Tay WT;Anand IS;Kraus WE;Liew HB;Ling LH;O'Connor CM;Piña IL;Richards AM;Shimizu W;Whellan DJ;Yap J;Lam CSP;Mentz RJ;ASIAN-HF;HF-ACTION investigators
Assessing health-related quality of life (HRQoL) in patients with heart failure (HF) are important goals of clinical care and HF research. We sought to investigate ethnic differences in perceived HRQoL and its association with mortality among patients with HF and left ventricular ejection fraction ≤35%, controlling for demographic characteristics and HF severity. We compared 5,697 chronic HF patients of Indian (26%), White (23%), Chinese (17%), Japanese/Koreans (12%), Black (12%), and Malay (10%) ethnicities from the HF-ACTION and ASIAN-HF multinational studies using the Kansas City Cardiomyopathy Questionnaire (KCCQ; range 0–100; higher scores reflect better health status). KCCQ scores were lowest in Malay (58±22) and Chinese (60±23), intermediate in Black (64±21) and Indian (65±23), and highest in White (67±20) and Japanese or Korean patients (67±22), after adjusting for age, sex, educational status, HF severity and risk factors. Self-efficacy, which measures confidence in the ability to manage symptoms, was lower in all Asian ethnicities (especially Japanese/Koreans [60±26], Malay [66±23] and Chinese [64±28]) compared to Black (80±21) and White (82±19) patients, even after multivariable adjustment (p<0.001). In all ethnicities, KCCQ strongly predicted 1-year mortality (HR 0.45, 95% CI 0.30–0.67 for highest vs lowest quintile of KCCQ; p for interaction by ethnicity 0.101). Overall, HRQoL is inversely and independently related to mortality in chronic HF, but is not modified by ethnicity. Nevertheless, ethnic differences exist independent of HF severity and comorbidities. These data may have important implications for future global clinical HF trials that use patient-reported outcomes as endpoints. NCT00047437 and NCT01633398
登录
查看更多内容
影响因子:
24
作者:
Heidenreich, PA;Spertus, JA;Williams, RE
通讯作者:
Williams, RE
影响因子:
5.9
作者:
Comin-Colet, Josep;Garin, Olatz;Elosua, Roberto
通讯作者:
Elosua, Roberto
影响因子:
13
作者:
Qian, Feng;Parzynski, Craig S.;Krumholz, Harlan M.
通讯作者:
Krumholz, Harlan M.
影响因子:
18.2
作者:
Pettersen, KI;Reikvam, A;Stavem, K
通讯作者:
Stavem, K
影响因子:
2.8
作者:
Jaarsma, T;Halfens, R;Diederiks, J
通讯作者:
Diederiks, J